Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by potstockscanadaon Dec 10, 2018 11:27pm
178 Views
Post# 29095191

RE:4 Reasons Why Aphria (APHA) Could Be a M&A Target

RE:4 Reasons Why Aphria (APHA) Could Be a M&A Target

Many issues I see in this article. Here are just 2. From the article:

"Compared to its peers, Aphria is pretty cheap. Aphria’s market cap is just a hair over $1 billion. There really is no reason behind this big discount." --- HUH?? Has author been asleep for the past week?

"Canadian cannabis market accounts for around $10 billion of a $500 billion global opportunity." --  I was just looking at global projections and found many sources stating anywhere from $55 Billion to $150 Billion. Now it's $500 Billion??


Alex8486 wrote: https://stocknews.com/news/apha-4-reasons-why-aphria-apha-could-be-a-ma-target/


 

Bullboard Posts